June 2026 Vol. 126, No. 6

Ehlers-Danlos syndrome and hypermobility spectrum disorder (HSD) are connective tissue disorders associated with musculoskeletal manifestations and significant psychiatric comorbidities. Psychoactive medications commonly utilized in these populations raise concerns regarding potential cardiac effects. This study explores associations between psychoactive medication utilization and electrocardiogram parameters in patients with hypermobile Ehlers-Danlos syndrome and HSD to provide insight into potential cardiac considerations in this population.

Access to mobile recording devices and the prevalence of telehealth encounters have increased dramatically in recent years. These circumstances create opportunities for patients to record their clinical encounters, and some states do not require permission from the physician to do so. State laws that define requirements to record conversations vary significantly, and clinicians may be unaware of their own states’ policies. This commentary explores the legislation governing recording laws, describes several cases involving recorded healthcare information, and reviews studies examining the risks and benefits of recording encounters.

Currently, there is no strong evidence or guideline recommendations for utilizing OMM when treating patients with postacute sequelae of SARS-CoV-2 (PASC). In this article, the authors describe a protocol for a large-scale prospective study to determine the effectiveness of OMM in treating PASC-related symptoms, to assess its impact on functional outcomes, and to monitor for adverse events related to OMT.